These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21501885)

  • 61. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
    Sato A; Rahman NIA; Shimizu A; Ogita H
    Cancer Sci; 2021 Oct; 112(10):4005-4012. PubMed ID: 34420253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.
    Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H
    Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging agents and regimens for hepatocellular carcinoma.
    Zhu XD; Sun HC
    J Hematol Oncol; 2019 Oct; 12(1):110. PubMed ID: 31655607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer.
    Akanji MA; Rotimi D; Adeyemi OS
    Oxid Med Cell Longev; 2019; 2019():8547846. PubMed ID: 31485300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics.
    Panigrahi DP; Praharaj PP; Bhol CS; Mahapatra KK; Patra S; Behera BP; Mishra SR; Bhutia SK
    Semin Cancer Biol; 2020 Nov; 66():45-58. PubMed ID: 31351198
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
    Sui Y; Ju C; Shao B
    J Cell Physiol; 2019 Nov; 234(11):20036-20045. PubMed ID: 30950057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy.
    Qin S; Li A; Yi M; Yu S; Zhang M; Wu K
    J Hematol Oncol; 2019 Mar; 12(1):27. PubMed ID: 30866992
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy.
    Nguyen TD; Shaid S; Vakhrusheva O; Koschade SE; Klann K; Thölken M; Baker F; Zhang J; Oellerich T; Sürün D; Derlet A; Haberbosch I; Eimer S; Osiewacz HD; Behrends C; Münch C; Dikic I; Brandts CH
    Blood; 2019 Jan; 133(2):168-179. PubMed ID: 30498063
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter.
    Elefantova K; Lakatos B; Kubickova J; Sulova Z; Breier A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells.
    Liu L; Zuo Z; Lu S; Wang L; Liu A; Liu X
    Biomed Pharmacother; 2018 Oct; 106():333-341. PubMed ID: 29966978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.
    Hu G; Zhang J; Xu F; Deng H; Zhang W; Kang S; Liang W
    Cancer Sci; 2018 May; 109(5):1357-1368. PubMed ID: 29516570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Yamashita K; Miyata H; Makino T; Masuike Y; Furukawa H; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
    Ann Surg Oncol; 2017 Dec; 24(13):4025-4032. PubMed ID: 29022200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.
    Chiu DK; Tse AP; Xu IM; Di Cui J; Lai RK; Li LL; Koh HY; Tsang FH; Wei LL; Wong CM; Ng IO; Wong CC
    Nat Commun; 2017 Sep; 8(1):517. PubMed ID: 28894087
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autophagy in Cancer Therapy.
    Fulda S
    Front Oncol; 2017; 7():128. PubMed ID: 28674677
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dysregulation of mitophagy in carcinogenesis and tumor progression.
    Chang JY; Yi HS; Kim HW; Shong M
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):633-640. PubMed ID: 28017650
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.
    Ye QH; Zhu WW; Zhang JB; Qin Y; Lu M; Lin GL; Guo L; Zhang B; Lin ZH; Roessler S; Forgues M; Jia HL; Lu L; Zhang XF; Lian BF; Xie L; Dong QZ; Tang ZY; Wang XW; Qin LX
    Cancer Cell; 2016 Sep; 30(3):444-458. PubMed ID: 27569582
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypoxic control of metastasis.
    Rankin EB; Giaccia AJ
    Science; 2016 Apr; 352(6282):175-80. PubMed ID: 27124451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Practical Guide to The Cancer Genome Atlas (TCGA).
    Wang Z; Jensen MA; Zenklusen JC
    Methods Mol Biol; 2016; 1418():111-41. PubMed ID: 27008012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanisms of Selective Autophagy in Normal Physiology and Cancer.
    Mancias JD; Kimmelman AC
    J Mol Biol; 2016 May; 428(9 Pt A):1659-80. PubMed ID: 26953261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.